Cargando…

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

The blood-brain barrier supplies brain tissues with nutrients and filters certain compounds from the brain back to the bloodstream. In several neurodegenerative diseases, including Parkinson's disease (PD), there are disruptions of the blood-brain barrier. Cerebrospinal fluid (CSF) has been wid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiménez-Jiménez, Félix J., Alonso-Navarro, Hortensia, García-Martín, Elena, Agúndez, José A. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227512/ https://www.ncbi.nlm.nih.gov/pubmed/25426023 http://dx.doi.org/10.3389/fncel.2014.00369

Ejemplares similares

An association study between Heme oxygenase-1 genetic variants and Parkinson's disease
por: Ayuso, Pedro, et al.
Publicado: (2014)

The Relationship Between Parkinson's Disease and Essential Tremor: Review of Clinical, Epidemiologic, Genetic, Neuroimaging and Neuropathological Data, and Data on the Presence of Cardinal Signs of Parkinsonism in Essential Tremor
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2012)

Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue
por: Agúndez, José A. G., et al.
Publicado: (2014)

Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2016)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease
por: del Hoyo, Pilar, et al.
Publicado: (2010)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
por: Alonso-Navarro, Hortensia, et al.
Publicado: (2020)

Current Treatment Options for REM Sleep Behaviour Disorder
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Neurochemical Features of Rem Sleep Behaviour Disorder
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2020)

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Sleep Disorders and Sleep Problems in Patients With Tourette Syndrome and Other Tic Disorders: Current Perspectives
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Coenzyme Q10 and Dementia: A Systematic Review
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Association between LAG3/CD4 gene variants and risk of Parkinson's disease
por: García‐Martín, Elena, et al.
Publicado: (2022)

Missense Gamma-Aminobutyric Acid Receptor Polymorphisms Are Associated with Reaction Time, Motor Time, and Ethanol Effects in Vivo
por: García-Martín, Elena, et al.
Publicado: (2018)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010)

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
por: Ma, Ling-Yan, et al.
Publicado: (2021)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
por: Noor Eddin, Ahmed, et al.
Publicado: (2023)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
por: Lian, Teng-hong, et al.
Publicado: (2020)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features
por: Griffiths, William J., et al.
Publicado: (2021)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson’s Disease
por: Shen, Xiaoli, et al.
Publicado: (2019)

Interactions between Flow Oscillations and Biochemical Parameters in the Cerebrospinal Fluid
por: Puy, Vincent, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
por: Irwin, David J., et al.
Publicado: (2013)

Increased Cerebrospinal Fluid S100B and NSE Reflect Neuronal and Glial Damage in Parkinson’s Disease
por: Papuć, Ewa, et al.
Publicado: (2020)

Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
por: Guo, Peng, et al.
Publicado: (2020)

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
por: Martínez, Carmen, et al.
Publicado: (2010)

Genomic Markers for Essential Tremor
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: Hatcher-Martin, J. M., et al.
Publicado: (2021)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer’s Disease
por: Paquet, Claire, et al.
Publicado: (2015)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dfcqe4n1qn7ee039emrpmu0g4p